Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance  by Yamani, Mohamad H. et al.
1232 JACC Vol. 25, No. 6 
May 1995:1232-8 
Exercise Intolerance in Chronic Heart Failure Is Not Associated 
With Impaired Recovery of Muscle Function or Submaximal 
Exercise Performance 
MOHAMAD H. YAMANI, MD,* PUNEET SAHGAL, MD,* LAUREN WELLS, PT, MS,[ 
BARRY M. MASSIE, MD, FACC*? 
San Francisco, California 
Objectives. This study investigated whether recovery of skeletal 
muscle function is impaired in patients with heart failure and 
whether impaired recovery is associated with abnormal submaxi- 
mal systemic exercise tolerance during repeated testing. 
Background. Patients with heart failure experience fatigue 
during daily activities. Because abnormalities of skeletal muscle 
play a role in their exercise intolerance, these symptoms may 
reflect a delay in muscle recovery and a resulting limitation in 
submaximal exercise tolerance. 
Methods. Two protocols were used. In protocol 1, knee extensor 
strength and endurance, and their recovery after fatiguing exer- 
cise, were evaluated in 11 patients (mean [-+SEM] age 62 -+ 5 
years, New York Heart Association functional class 2.3 + 0.2, 
ejection fraction 24 -+ 5%) and in 10 age-matched sedentary 
control subjects. Protocol 2 examined the recovery of knee exten- 
sor endurance and submaximal exercise tolerance, as quantified 
on a self-powered treadmill, over 24 h in 18 patients (mean age 
65 -+ 3 years, functional class 2.4 _+ 0.2, ejection fraction 23 -+ 3%) 
and in 10 control subjects. 
Results. Peak oxygen consumption was reduced in both heart 
failure groups (15.4 -+ 1.4 and 15.6 -+ 1.0 ml/kg per rain) 
compared with that in the respective control groups (23.1 + 2.9 
and 25.6 _+ 1.0 ml/kg per min, both p < 0.05), as was muscle 
endurance but not muscle strength. In protocol 1, knee extensor 
endurance recovered more slowly in the patients than in control 
subjects (to 62 -+ 4% and 87 + 7% of the baseline value after 
5 rain, respectively, p < 0.05). In protocol 2, submaximal exercise 
tolerance was lower in the patients with heart failure than in 
control subjects (1,075 -+ 116 vs. 1,390 -+ 110 m), but knee 
extensor endurance and walking distance recovered fully by 10 
and 30 min, respectively. 
Conclusions. Although these findings confirm earlier studies 
that demonstrated impaired muscle endurance in patients with 
heart failure, the results provide no evidence that recovery of 
either muscle function or submaximal exercise tolerance is de- 
layed beyond the initial 5 to 10 rain after exercise. 
(J Am Coil Cardiol 1995;25:1232- 8) 
Exercise intolerance and fatigue during daily activities are the 
most frequent symptoms in patients with mild and moderate 
congestive heart failure (1,2). A paradoxic but well recognized 
finding is the discordance between the severity of these 
symptoms, as well as quantitative indexes of exercise capac- 
ity, and any measurements of cardiac performance, such as 
ejection fraction and rest hemodynamic indexes (3-5). Al- 
though reduced exercise cardiac output and blood flow to 
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exercising muscle and alterations in both left ventricular 
diastolic and right ventricular function play a role in this 
limitation (6-8), an additional likely explanation for this 
dissociation is that exercise is limited in part by alterations 
in skeletal muscle that occur either as a manifestation f the 
syndrome of heart failure or as a consequence of the 
resulting decrease in activity (9-11). 
However, patients with congestive heart failure rarely per- 
form activities at levels approaching peak oxygen consumption 
(Vo2) and often have fatigue with repeated low level exertion 
(12). Whether these symptoms are associated with incomplete 
recovery of submaximal exercise tolerance or reflect abnormal- 
ities of skeletal muscle recovery has not been examined. To test 
this hypothesis, we used two protocols. Protocol 1 (short-term 
recovery) examined the recovery of strength and endurance of 
the knee extensors during the initial 5 rain after a brief 
fatiguing bout of exercise of this muscle group. When early 
recovery of muscle function was found to be abnormal, proto- 
col 2 (long-term recovery) was designed to examine the recovery 
of muscle ndurance and submaximal exercise tolerance over a 
period of 24 h. 
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Methods  
Separate groups of patients and control subjects were 
recruited for protocol 1 (short-term recovery) and protocol 2 
(long-term recovery). 
Patients. Male patients with a history of congestive heart 
failure (New York Heart Association functional classes I to 
IV) of at least 6 months in duration participated in both 
protocols. The diagnosis of congestive heart failure was based 
on a history of dyspnea on exertion, fatigue or fluid retention, 
along with left ventricular dysfunction confirmed by a radio- 
nuclide ejection fraction <40% (range 5% to 37%). Patients 
were excluded if they had had a myocardial infarction within 6 
months or if systemic exercise was limited by symptoms other 
than fatigue or dyspnea. Other exclusion criteria were hemo- 
dynamically important valvular disease, angina pectoris or 
exercise limitation by pulmonary, peripheral vascular, arthritic 
or neurologic disease. 
Protocol 1 included 11 patients, of whom 7 had ischemic 
cardiomyopathy and 4 primary myocardial disease (mean 
[-+SEMI age 62 +_ 5 years, functional class 2.3 _+ 0.2, ejection 
fraction 24 _+ 5%). All 11 patients were receiving digitalis, 
diuretic agents and angiotensin-converting e zyme inhibitors. 
Protocol 2 included 18 patients, 13 with ischemic and 5 with 
dilated cardiomyopathy (mean age 65 _+ 3 years, functional 
class 2.4 _+ 0.2, ejection fraction 23 _+ 3%). All 18 patients were 
receiving diuretic agents and angiotensin-converting e zyme 
inhibitors, and 15 were taking digitalis. Eight patients were also 
receiving isosorbide dinitrate. 
Control subjects. Age-matched sedentary control subjects 
were recruited from employees at the San Francisco Veterans 
Affairs Medical Center. These subjects had no history of heart 
disease and no cardiac, peripheral vascular or musculoskeletal 
abnormalities on careful questioning or by physical examina- 
tion (protocol 1 = 10 control subjects, mean age 58 + 4 years; 
protocol 2 - 10 control subjects, mean age 64 _+ 3 years). 
The protocols were approved by the Committee on Human 
Research at the University of California San Francisco, and 
written informed consent was obtained from all participants. 
Physiologic measurements. Respiratory gas exchange analy- 
sis. To determine the functional capacity of the patients with 
congestive heart failure and the conditioning status of the 
control subjects, we measured peak systemic Vo 2 in all subjects 
during cycle ergometry. Testing was performed on an electron- 
ically braked cycle ergometer (Quinton) that maintained con- 
stant work load at pedal frequencies of 50 to 75 rpm, in an 
air-conditioned laboratory with an ambient temperature of 22 
to 24°C and humidity of 30% to 40%. Before exercise, the 
subjects rested upright on the cycle for 5 rain. Exercise was 
initially performed unloaded for 2 rain. The load was then 
increased to 200 kg.m/min (kpm) for 2 rain and then by 
100 kpm every 2 rain until exhaustion. Exhaustion was defined 
as the inability to maintain a pedal frequency of >50 rpm. 
Standard verbal encouragement was used for all subjects. 
Respiratory gas exchange was monitored on a breath by breath 
basis using a metabolic art (Medical Graphics, DX 2300). 
Exercise was considered adequate if the respiratory exchange 
ratio (carbon dioxide consumption [Vco2]/Vo2) exceeded 1.0. 
Peak systemic Vo2 was defined as the highest Vo 2 reached 
during exercise. 
Muscle function testing. For both protocols, knee extensor 
function was assessed using an exercise dynamometer (Cybex 
340) according to a modification of previously published 
procedures (11). This device consists of a lever arm that 
continuously records force production, measured as torque in 
ft-lb, during either isometric (when the dynamometer rota- 
tional rate is set at 0°/s) or isokinetic muscle contractions. Each 
subject was stabilized on the adjustable dynamometer testing 
chair. To prevent hip and upper body movement, the back rest 
was positioned at a 15 ° incline from vertical and a seat belt and 
shoulder strap were used to anchor the subject o the back rest. 
The subject's right knee was then aligned with the input axis of 
the lever arm, and the ankle was attached to the distal end of 
the lever arm. Patients were familiarized with the apparatus 
before testing. All tests were conducted by the same personnel. 
The specific exercise procedures are described later with the 
individual protocols. 
Assessment ofsubmaximal exercise tolerance. In protocol 2, 
subjects underwent serial assessment of their submaximal 
exercise tolerance. This was accomplished by quantifying the 
distance walked during a 9-rain period on a self-powered 
treadmill (Tunturi Jogger II) with the incline set at 7 °. All tests 
were supervised by the same physician who provided a stan- 
dardized set of directions and verbal encouragement before 
the test. Subjects were allowed to pause when necessary 
because of leg or systemic fatigue or dyspnea, and the number 
of stops and time to the first stop were recorded. 
Protocol 1: immediate recovery. Protocol 1 was designed to 
quantify knee extensor strength and endurance inpatients with 
congestive heart failure and in age-matched sedentary controls 
and the recovery of these variables during the 5 rain after the 
initial test. 
Kalee extensor strength and the time course of its recovery were 
assessed as follows: Three brief (3-s) maximal voluntary iso- 
metric contractions were performed separated by 60 s of rest. 
The highest value was taken as the isometric strength. After a 
5-rain rest, each subject performed a sustained maximal vol- 
untary contraction. Subjects continued to contract maximally 
until the isometric force declined to 60% of the initial maximal 
force. The time to this end point was defined as the isometric 
endurance. Then, to evaluate the time course of subsequent 
recovery of strength, each subject performed brief 3-s maximal 
voluntary isometric ontractions at15, 30, 45, 60, 90, 120, 180 
and 240 s after the sustained maximal contraction was released. 
These force measurements were normalized to the initial 
maximal force and expressed as a percent of maximal force. 
Knee extensor endurance and the time course of its recovery 
were assessed uring a second session 24 h later. For these 
measurements the lever arm, instead of being fixed, was 
adjusted to maintain avelocity of 60°/s for the entire range of 
motion. In this isokinetic mode the dynamometer continuously 
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records the torque produced at the selected angular velocity 
during the knee extension. Unlike in isotonic muscle testing, 
the controlled variable during isokinetic contraction is the 
velocity of the muscle contraction and not the applied resis- 
tance. After familiarization with the dynamometer and a 
standardized practice period, the subject performed exercise 
protocol which consisted of repetitive knee extensions (each 
lasting -2  s). Knee extensions were continued until the peak 
torque produced uring successive xtensions declined to 
60% of its initial value. The number of repetitions required 
for torque to decline to 60% was defined as the baseline 
endurance. The subjects were allowed to recover for 90 s and 
then asked to repeat the same protocol. The number of 
repetitions required for torque to decline to 60% was 
defined as the endurance at 90 s. Each subject rested again 
for an additional 180 s and repeated the exercise protocol a 
third time. The number of repetitions required for torque to 
decline to 60% was defined as the endurance at 5 min (the 
total of the first 90 s of delay, the 30 s for the intervening 
exercise period and the second 180-s delay). Recovery of 
endurance was quantified from the number of repetitions at 
90 s and 5 min normalized to baseline ndurance and also 
expressed as a percent. 
Protocol 2: long-term recovery. Protocol 2 was designed to 
determine whether muscle function recovers more slowly in 
patients with congestive heart failure over a period of 24 h and, 
if so, whether delayed recovery is associated with diminished 
submaximal exercise tolerance. First, isometric strength was 
measured as described in protocol 1. Then, knee extensor 
endurance was measured using the same exercise dynamometer 
but with the velocity set at 90°/s. Patients performed 25 repetitive 
knee extensions. Endurance was determined as the ratio of 
average peak torque during the final three to the initial three 
repetitions. Peak torque and total work performed were also 
recorded. Knee extensor endurance was then remeasured after 
10 rain, 30 rain, 1 h, 3 h and 24 h, and recovery of muscle 
endurance was evaluated as the endurance ratio and total work 
on these tests divided by the initial measurements of these 
parameters. 
Submaximal exercise tolerance was quantified using the 
9-min self-powered treadmill test, and recovery of submaximal 
exercise tolerance was evaluated by examining the ratios of 
9-min walking distance during repeated tests performed 
30 min, 1 h, 3 h and 24 h after the initial procedure. Muscle 
function and submaximal exercise tolerance were assessed on 
successive days in random order. 
Statistics. Intergroup comparisons ofsingle measurements 
were performed using Student unpaired t tests. The signifi- 
cance of differences between serial measurements was assessed 
by repeated measures analysis of variance and Newman-Keuls 
multiple comparison procedure. Differences at the p < 0.05 
level were considered statistically significant; p < 0.10 is 
indicated for informational purposes. Results are expressed as 
mean value _+ 1 SEM. 
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Figure 1. Muscle ndurance quantified as the ratio of the number of 
repetitive knee extensions (numbers within bars) required to produce 
a decline in peak torque to 60% of initial. Eleven patients with heart 
failure (solid bars) had reduced endurance atbaseline. On repeat 
testing after 90 s and 5 min, endurance r mained lower and did not 
recover to the same xtent. Open bars = 10 control subjects. *p < 0.05, 
**p < 0.01 versus baseline. 
Resu l ts  
Systemic exercise capacity. Exercise capacity was reduced 
in both congestive heart failure groups compared with their 
respective control groups. Among participants in protocol 1, 
peak Vo 2 was 15.4 _+ 1.4 and 23.1 _+ 2.9 ml/kg per rain, in the 
patients with congestive heart failure and control subjects, 
respectively (p < 0.05). Similarly, in protocol 2 the peak Vo2 
values were 15.6 _+ 1.0 and 25.6 _+ 1.0 ml/kg per min, 
respectively (p < 0.001). 
In protocol 2, submaximal exercise tolerance was also lower 
in the patients with congestive heart failure. Their 9-min 
walking distance was 367 _+ 32 m versus 667 _+ 27 m in the 
control subjects (p < 0.001), and 17 of 18 patients versus 2 of 
10 control subjects paused at least once during the protocol 
(p < 0.01). 
Baseline muscle function. Isometric strength tended to be 
lower in patients with congestive heart failure in both protocols 
(95 _+ 11 vs. 105 __ 8 ft-lb in protocol 1; 80 _+ 4 vs. 90 + 6 ft-lb 
in protocol 2, p = NS for both). In protocol 1 isometric 
endurance, defined as the time elapsed before isometric force 
declined to 60% of the baseline value, was significantly re- 
duced in patients with congestive heart failure (39.2 -+ 3.6 vs. 
74.2 _+ 8.3 s, p < 0.002). 
Baseline muscle endurance was measured using different 
procedures in the two protocols. In protocol 1, endurance was 
quantified by the number of extensions performed with the 
dynamometer set at 60°/s before peak torque declined to 60% 
of its initial value. As indicated in Figure 1, this was signifi- 
cantly lower in patients with congestive heart failure (17.5 _+ 
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Table 1. Serial Measurements (mean _+ SEM) of Muscle Function and Recovery of Submaximal Exercise Tolerance in Protocol 2 
Baseline 10 min 30 min 1 h 3 h 24 h 
Knee cxtensor function 
Maximal voluntary force (ft-lb) 
Control group 90 + 6 
CHF group 80 -+ 4 
Endurance ratio 
Control group 
CHF group 
Work (ft-lb) 
Control group 
CHF group 
Submaximal exercise tolerance 
9-rain walking distance (m) 
Control group 667 +_ 27 
CHF group 367 + 32§ 
89 + 4 92 - 5 89 ~- 4 94 ± 5 86 -+ 4 
81 +4 8(1+6 78-+6 81 .+4 85.+6 
(I.58 -+ 0.02 0.63 -+ 0.04 0.66 + 0.04* 0.68 + 0.05* (I.66 -+ 0.05* 0.66 -+ 0.04* 
0.51 .+ 0.03 0.50 -+ 0.03t 0.57 + 0.035 0.61 +_ 0.03* 0.55 + 0.03:~ 0.58 + 0.02:I: 
1,390 -+ 1 l0 1,419 * 96 1,388 + 95 1,382 ± 94 1,431 -+ 107 1,463 -+ 121 
1,075 + 116[ 1,007 = 107t 1,(172 -+ l16t 1,066 + l16t 1,086 _+ 96t 1,110 _+ 118t 
675 -+ 27 679 ~+ 34 684 -+ 34 670 _+ 31 
364 _+ 37§ 377 + 38§ 397 _+ 40§ 368 -+ 36§ 
*p < 0.05 versus baseline, tp < 0.05, $p < 0.10, §p < 0.01, congestive h art failure (CHF) group (n - 18) versus control group (n 10). 
2.4 vs. 28.6 ± 2.6, p < 0.005). In protocol 2 (Table 1), 
endurance was quantified as the ratio of the mean peak torque 
during the final 3 extensions (of 25) to the mean peak torque 
during the initial 3 extensions with the dynamometer set at 
90°/s. This value also tended to be lower in the patients with 
congestive heart failure, but the difference was not statistically 
significant (0.51 ± 0.03 vs. 0.58 +_ 0.02, p = 0.10). However, the 
total amount of work performed uring the 25 extensions was 
significantly lower in the congestive heart failure group 
(1,075 + 116 vs. 1,390 + 110 ft-lb, p < 0.05). 
Short-term recovery (protocol 1). The measurements of
isometric strength from the sustained isometric exercise pro- 
tocol are shown in Table 2. Neither group had fully recovered 
to their baseline value at the end of 240 s, although the 240-s 
measurement was not significantly different from baseline in 
the control group. There were no significant intergroup differ- 
ences in isometric strength at any time, analyzed either as 
absolute values or as a percent of the baseline value. 
In contrast, recovery of endurance was significantly slower 
in the congestive heart failure group (Fig. 1). After both 90 and 
300 s, both the number of repetitions required for peak torque 
to decline to 60% and the number of repetitions analyzed as a 
percent of the baseline number were reduced compared with 
that in control subjects. Five minutes after the initial isokinetic 
exercise run, patients completed 10.7 + 3.2 repetitions (62 + 
4% of baseline) compared with the 23.6 _+ 1.7 repetitions 
(87 ± 7% of baseline) completed by the control subjects (p < 
0.05 for both number of repetitions and percent of recovery). 
Long-term recovery (protocol 2). In this protocol 2 we 
measured skeletal muscle function and 9-min walking distance 
at several times up to 24 h (Table 1). Isometric strength 
remained somewhat lower in the patients with congestive heart 
failure, but at no time point was it significantly different from 
that in the control group analyzed either as an absolute value 
or as a percent of baseline. Furthermore, in neither group did 
the later measurements differ from those at baseline. Knee 
extensor endurance as quantified by the work performed 
during 25 consecutive xtensions was significantly reduced in 
the patients with congestive heart failure at each time point. 
The endurance ratio tended to be lower but was not signifi- 
cantly different from that in the control subjects. However, 
beginning at 10 min and extending to 24 h, the values of both 
these measurements showed no significant decline from base- 
line in either group, indicating complete recovery of endurance 
throughout the period of observation. Indeed, the endurance 
ratio tended to be higher at subsequent times, suggesting a
"warm-up" phenomenon. This increase from baseline was 
significant at 30 min, 1 h, 3 h and 24 h in the control subjects 
and at 1 h in the patients with congestive heart failure. As 
illustrated in Figure 2, in only two patients (one with functional 
class lI and one with functional class l I I  symptoms) did the 
endurance ratio remain < 100% for the first hour. On the basis 
Table 2. Recove U of Isometric Strength in Protocol 1 (mean + SEM) 
Time After Sustained Contraction (s) 
Baseline 15 30 45 60 90 120 180 240 
Control group (n 10) 
Force (ft-lb) 105 + 8 77 ~_ 8* 85 - 7* 85 - 9* 88 + 9* 87 -+ 10' 89 -+ 10" 93 -+ 10' 96 _+ 8* 
Percent of baseline 73 +_ 4 81 -- a 81 - 5 84 = 6 82 _+ 6 84 _+ 6 87 .+ 5 91 _+ 4 
CHF group (n = 11) 
Force (ft-lb) 95-+11 73-+9 ~ 77-+10' 77+10 * 77=10' 79=11' 81--10' 84-+9* 86+8 *
Percent of baseline 77 .+ 4 80 .+ 4 81 + 4 80 .+ 4 82 ± 4 84 _- 5 87 _+ 5 90 _+ 5 
*p < 0.05 versus baseline; there were no significant differences between congestive h art failure (CHF) and control groups. 
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Figure 2. Recovery, of endurance ratio (ER) over time for the 
individual patients with heart failure. The measurements at 10, 30 and 
60 rain and 3 and 24 h are expressed aspercents of the baseline 
measurements. Triangles - functional classes I and II; circles - 
functional c ass Ill: squares = functional c ass IV. 
of the interest variability in the control group, the power to 
detect a 20% decrease from baseline for the group as a whole 
at any subsequent time was 95%. 
The 9-rain walking distance remained significantly lower in 
the congestive heart failure group throughout the 24-h obser- 
vation period, but both groups had fully recovered by 30 rain, 
and no intergroup differences were noted in the ratio of 
distance walked during subsequent tests to the baseline dis- 
tance. The individual measurements are shown in Figure 3. 
Again, in only two subjects (one with functional class lII and 
one with functional class IV symptoms) did the follow-up 
walking distances remain >10% below that at baseline for the 
first 3 h. For the group as a whole, the estimated power to 
detect a 10% reduction from baseline at any subsequent time 
was 88%. 
Discussion 
A growing body of evidence from published reports points 
to an important contribution of skeletal muscle dysfunction to 
the limitation of systemic exercise capacity in some patients 
with congestive heart failure (6,7,9-11), although it remains 
uncertain as to whether these abnormalities are primary or 
Figure 3. Recovery. of 9-rain walking distance for the individual 
patients with heart failure. Postbaseline measurements areexpressed 
as percents of the baseline values. Symbols as in Figure 2. 
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occur as a result of limitation in activity. Most previous tudies 
focused on the relation between maximal exercise capacity as 
quantified by peak systemic Vo 2 and measurements of muscle 
function (11,13,14), metabolism (15-20) and biochemistry or 
morphology (21-24). However, patients rarely achieve this 
level of exertion and commonly complain of fatigue during 
repeated low-level activities. Therefore, we designed the 
present study to test the hypothesis that symptoms and activity 
intolerance may be caused by incomplete recovery of muscle 
function and submaximal exercise capacity. 
Major findings. Several findings of the present study pro- 
vide additional insight into the phenomenon ofexercise intol- 
erance in the syndrome of congestive heart failure. Confirming 
previous tudies from our laboratory (11,25,26), we found that 
muscle endurance was impaired during both isometric and 
isokinetic testing protocols. The first important new finding is 
that after an initial brief bout of knee extensor exercise, which 
caused identical levels of fatigue in both groups, the patients 
with congestive heart failure displayed delayed recovery in 
their ability to perform the same type of exercise before the 
onset of fatigue, which persisted for at least 5 rain. However, 
after 10 rain and at later times after the initial exercise 
protocols, there were no significant intergroup differences in
the recovery of either isometric strength or isokinetic endur- 
ance. Most important, here was no decline in the submaximal 
exercise tolerance of patients with congestive heart failure 
during serial testing after 0.5, 1, 3 and 24 h. These latter 
findings indicate that delayed recovery of muscle function or 
submaximal exercise tolerance isnot the cause of symptomatic 
complaints in patients with mild to moderate congestive heart 
failure. 
These results are surprising for several reasons. Results 
from our laboratory (11) have indicated that increased muscle 
fatiguability and reduced muscle endurance are consistent 
findings in symptomatic patients with congestive heart failure. 
Muscle strength is relatively maintained; when it is abnormal 
this appears to reflect muscle atrophy (13,14,25). Although the 
results have not been entirely consistent, studies (21-23,27-29) 
evaluating muscle biopsy specimens from patients or tissue 
from animal models of heart failure have generally demon- 
strated a decreased number of the less fatiguable slow twitch 
(type I) fibers, an increase in the more fatiguable fast twitch 
(type II) fibers and reductions in oxidative enzymes and 
volume of mitochondria. Using phosphorus-31 magnetic reso- 
nance spectroscopy, several groups have shown impaired oxi- 
dative metabolism during exercise in muscles from patients 
with heart failure (15-20). Particularly relevant to the present 
discussion is the finding of delayed metabolic recovery after 
exercise, the degree of which has been inversely related to 
measurements of exercise capacity (17,30,31). All of these 
findings are consistent with abnormalities of muscle, which 
might be expected to cause not only increased muscle fatigue 
but also impaired recovery of muscle function. The results of 
protocol 1, showing at least a short-term delay (5 rain) in the 
recovery of muscle endurance, led to the combined evaluation 
of muscle function and exercise over a period of 10 rain to 24 h 
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in protocol 2 to determine the persistence and relevance of 
more prolonged abnormalities of recovery. Despite significant 
reductions inboth muscle endurance and exercise tolerance in 
patients with congestive heart failure at baseline, these results 
basically failed to confirm that their recovery of muscle func- 
tion is abnormal over these longer periods or that they exhibit 
a decline in submaximal exercise tolerance during repeated 
bouts of exercise. 
Mechanism of exercise intolerance in congestive heart 
failure. If impaired recovery, of muscle function and exercise 
tolerance is not the cause of the symptoms in patients with 
congestive heart failure, what is responsible? With regard to 
maximal exercise capacity, it is likely that abnormalities of periph- 
eral blood flow play a role by reducing oxygen delivery to 
exercising muscle (7,8,32,33). It is also likely that the changes in 
muscle recognized in recent years (6,7,9,10), including muscle 
atrophy (13,14,25,34), changes in fiber type distribution 
(21,22,24,28,29) and reduced oxidative capacity (15-18,21- 
24,27,28), play a role. The limitation of submaximal exercise 
tolerance and the basis for the predominant symptom of fatigue 
are less well studied and understood. Muscle fatigue is a complex 
phenomenon that can be exacerbated bychanges in the central 
nervous ystem, peripheral nerves, neuromuscular junction, exci- 
tation-contraction coupling, muscle metabolism and the muscle 
contractile apparatus (35,36). These mechanisms were not ex- 
plored in the present study but have been the subject of previous 
work (26,37). At least during a single bout of maximal muscle 
contractions, central fatigue and other changes proximal to the 
muscle itself do not appear preferentially toaffect patients with 
congestive heart failure. However it is certainly possible that 
central fatigue, perhaps experienced asmotivational failure, may 
play a role during repeated activities although it could not be 
demonstrated bythe serial assessments of submaximal exercise 
tolerance in the present study. Persistent elevations inneurohor- 
mone levels, which have been documented after maximal exercise 
(38,39), or of cytokines, or a reduction in endorphins could also 
explain a perception of fatigue. Changes in muscle metabolism 
have been mentioned previously, and these may in part reflect 
reduced blood flow to exercising muscle ven at submaximal 
levels of exertion (7,8). The more rapid depletion of high energy. 
phosphates, increased accumulation of intracellular phosphate 
ions and more rapid acidification demonstrated in patients with 
congestive heart failure could all cause fatigue (35,36,40,41). The 
temporal course of metabolic recovery in muscle is consistent with 
the findings of the present study. Muscle metabolism usually 
recovers by 5 to 10 rain (42-44), but the slower ecovery in 
congestive heart failure could easily explain the delayed recovery. 
of endurance at 5 rain. Furthermore, because metabolic recovery 
is usually complete by 10 to 15 rain, even in patients with 
congestive heart failure (except after extremely strenuous exer- 
tion) (15,17,31), the return to baseline levels of muscle function 
and exercise tolerance at the later times is also consistent with the 
previously described alterations of muscle metabolism. Study 
limitations. 
Study limitations. Several aspects of the present study 
warrant comment. Because the results evaluating recovery of 
muscle function and exercise tolerance beyond the first 5 rain 
were negative, it is important to examine the power of this 
study to detect meaningful degrees of incomplete r covery. By 
power analysis, the probability of detecting 20% reductions in
endurance ratio or 10% reductions in 9-min walking distance 
was 88% and 95%, respectively. Therefore, it is unlikely that 
this study would have missed abnormalities of recovery affect- 
ing the group as a whole. 
These results cannot be generalized to patients who differ 
from those included in the present study, which was limited to 
men with chronic stable heart failure, all of whom were <75 
years old. Although the measures of exercise capacity and 
muscle function are standard, they each have limitations. Cycle 
ergometry usually provides lower measurements of peak Vo2 
than treadmill exercise because it involves fewer muscles. 
Some subjects may approach their maximal exercise capacity 
during the 9-min walk protocol, although the ability to rest 
during the protocol still makes this a measure of submaximal 
capacity. Muscle function was measured inthe knee extensors, 
which may not be the limiting factor during walking. 
The two protocols were not conducted in the same groups 
of subjects because they were performed sequentially over a 
period of 2 years. Nonetheless all characteristics of both the 
patient and control subjects were similar over the two proto- 
cols, including the baseline measurements of muscle function 
and exercise capacity. Some confusion may have been engen- 
dered by using different regimens for measuring isokinetic 
endurance inthe short- and long-term recovery protocols. The 
choice of the more strenuous 60°/s dynamometer velocity (the 
slower the velocity, the greater the resistance during isokinetic 
exercise) for protocol 1 was based on the goal of achieving a
reduction in peak torque to 60% of the initial value in a fairly 
short time in the control subjects, so the time sequence of the 
measurements would be similar in the groups. The use of 25 
repetitions at a 90°/s velocity was based on the desire to have 
regimens of equal but relatively long duration, and this velocity 
provided a regimen that could be completed by all patients 
with congestive heart failure and still cause substantial fatigue 
in most controls. 
The tests of muscle function and exercise tolerance were 
carried to the same level of fatigue (protocol 1) or were based 
on self-determined nd points (protocol 2). In both protocols, 
the control subjects thus performed more work or a higher 
level of exercise, which could confound subsequent assessment 
of recovery. Thus although recovery rates were similar for most 
measurements, this may not have been the case if the same 
absolute level of exercise had been performed. Nonetheless, 
given the clinical question of whether abnormal postexercise 
recovery plays a role in subsequent exercise limitation, using 
matched relative levels of exercise or self-determined nd 
points seems more appropriate. 
Conclusions. This study confirms previous work from this 
and other laboratories demonstrating that skeletal muscle 
function is abnormal in patients with congestive heart failure. 
However, it provides no evidence that the recovery of skeletal 
muscle function is impaired beyond the initial few minutes 
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after exercise. Furthermore, despite the common complaint of 
fatigue and inability to perform repetitive submaximal activi- 
ties, submaximal exercise tolerance was maintained during 
serial tests performed over 24 h. Therefore, these symptoms 
are better explained by central factors, such as an altered 
perception of fatigue, or by the same abnormalities limiting 
maximal exercise that continue to operate during repeated 
activities. 
We acknowledge the assistance of Susan Ammon, RN, Elaine Der, MS, RNP 
and Kim Prouty, RN. 
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